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Ineffective transgene expression in a sufficient amount of target cells is still a limitation in retroviral vector mediated gene therapy. Thus,
we systematically evaluated four genetic modulators, (i) the woodchuck posttranscriptional regulatory element (WPRE), (ii) the mouse RNA
transport element (RTE), (iii) the constitutive transport element (CTE) of the simian retrovirus type 1 (SRV-1), and (iv) the 5V untranslated
region of the human heat shock protein 70 (Hsp70 5VUTR), all of them involved in the posttranscriptional control of mRNA nucleo/
cytoplasmatic transport, RNA stability, and translation efficiency, in an MLV-based retrovirus vector context. Insertion of the WPRE into the
retrovirus vector resulted in enhancement of transgene expression (EGFP) both in transfected virus producing cells as well as in infected
recipient cells irrespective of the location in the vector. The best effect was observed with two copies of the WPRE, 3V of the transgene and in
the 3V untranslated region of the vector backbone. However, oligomerization of this element does not further increase transgene expression.
Presence of the WPRE resulted also in an increase in virus production. Introduction of the CTE and/or RTE in the retroviral vector did not
alter transgene expression and infectious particle production. Positive effects were observed only in vectors harboring the CTE and/or RTE in
combination with the WPRE. The activity of the Hsp70 5VUTR as a translational enhancer was found to be negligible in the context of the
retroviral vector. However, interference of the Hsp70 5VUTR strong secondary structure with the packaging sequence of the viral RNA was
experimentally excluded as being the cause of this. These data suggest that only the WPRE is a suitable element for the improvement of
transgene expression and oncoretroviral vector production.
D 2005 Elsevier Inc. All rights reserved.Keywords: Retrovirus vector; RNA transport element (RTE); CTE; WPRE; Hsp70Introduction
Retroviral vectors are the most widely used delivery
vehicles for human gene therapy (http://www.wiley.co.uk/
genmed/clinical). However, the inability to achieve ther-
apeutic levels of transgene expression in sufficient numbers
of specific target cells still remains the obligatory problem0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.06.037
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E-mail address: salmons@austrianova.com (B. Salmons).(Greco et al., 2002). To overcome this obstacle, modulation
of the recombinant mRNA at the posttranscriptional level
has become an important consideration in the design of gene
therapy vectors in general.
Most mRNAs are spliced and polyadenylated prior to their
export from the nucleus to the cytoplasm (Hastings and
Krainer, 2001; Weis, 2002). However, for the retroviral life
cycle, the presence of non-spliced forms of the viral RNA in
the cytoplasm is indispensable as well. To that end, many
retroviruses have developed transport mechanisms to achieve
this goal. In complex retroviruses, trans-acting proteins, such005) 1 – 11
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single spliced RNA. Cis-acting sequences called constitutive
transport elements (CTE) were identified in several simple
retroviruses, including Mason-Pfizer monkey virus
(MPMV), simian retrovirus type D (SRV-1), Rous sarcoma
virus (RSV), and endogenous murine retroviruses (Bray et
al., 1994; Zolothukin et al., 1994; Paca et al., 2000; Wodrich
et al., 2001). CTEs interact directly with cellular factors such
as the tip-associated protein (Tap) and cause export of
unspliced RNAs (Gruter et al., 1998).
Woodchuck hepatitis virus (WHV) harbors a posttran-
scriptional regulatory element (WPRE, Donello et al., 1998)
that facilitates nucleocytoplasmic transport of RNAmediated
by several alternative pathways that may be cooperative
(Popa et al., 2002). In addition, the WPRE has been shown to
act on additional posttranscriptional mechanisms to stimulate
expression of heterologous cDNAs (Zufferey et al., 1999).
Sequences involved in the transport of mRNAs from
the nucleus to cytoplasm have also been identified in
several cellular genes (Ainger et al., 1997; Huang and
Carmichael, 1997; Bassel et al., 1999). Most recently,
using a Rev- and RRE-mutant of an HIV-1 proviral
clone, a mouse posttranscriptional regulatory element
involved in RNA cytoplasmic transport (RTE) has been
identified (Nappi et al., 2001).
Regions flanking the coding sequences in eukaryotic
mRNA molecules also contain elements involved in
regulation of mRNA stability, transport, subcellular local-
ization, and translation efficiency (Conne et al., 2000;
Pesole et al., 2001; Wilkie et al., 2003). Specific regions
capable of enhancing translation of the downstream genes
were identified in the 5V untranslated regions (UTR) from
the vascular endothelial growth factor (VEGF) gene and the
human heat shock protein 70 (Hsp70) gene (Huez et al.,
1998; Vivinus et al., 2001).
Some of these cis-acting elements have been already
used in current viral vector systems to achieve more potent
transgene expression in the target cells. Enhanced transgene
expression in adenovirus vectors, adeno-associated virus
vectors, lentivirus vectors, and MLV-derived vectors harbor-
ing WPRE has been reported (Loeb et al., 1999; Mautino
and Morgan, 2002; Ketteler et al., 2002; Xu et al., 2003).
Constitutive transport elements of MPMV or SRV-1 have
been exploited in order to improve titer and safety of
lentivirus and MLV vectors (Mautino et al., 2000; Wodrich
et al., 2000; Zhao et al., 2000).
In the present study, we describe the systematic evalua-
tion of four different genetic elements, qualified for the
regulation of expression both at the posttranscriptional and
translational level, in the context of an oncoretroviral vector.
A set of MLV-based retroviral vectors expressing the
enhanced green fluorescent protein gene (EGFP) were
progressively modified to include modulators of the
nuclear/cytoplasmatic RNA transport (WPRE, CTE, RTE)
as well as a translation enhancer element (Hsp70 5VUTR).
To achieve the best impact on transgene expression, theseelements were inserted either alone or in combination at
various locations in the viral vector. Based on the obtained
data, none of the alternative transport elements tested led to
a reasonable increase in vector performance in terms of
expression of the vector-inserted transgene except the
WPRE. Thus, the data presented here are of importance
for other researchers with respect to the choice of the most
suitable element for the improvement of oncoretroviral
vectors.Results and discussion
WPRE facilitated enhancement of transgene expression and
viral titer is position and copy number independent
The use of heterologous tissue-specific promoters
inserted into the U3 region of the MLV 3V long terminal
repeat (LTR) allows tissue-specific expression of the trans-
ferred gene in promoter conversion (ProCon) vectors
(Mrochen et al., 1997; Saller et al., 1998; O¨ztu¨rk-Winder
et al., 2002). Unfortunately, the replacement of elements
within the long terminal repeats (LTRs) of retroviral vectors
to achieve such transcriptional targeting is often associated
with decreases in both titer and transgene expression
(Hlavaty et al., 2004a, 2004b). Strategies exploiting the
insertion of cis-acting elements like the WPRE which is
known to facilitate nucleocytoplasmic transport and thereby
increase transgene expression, have been employed to
overcome these drawbacks in oncoretroviral, and more
frequently in lentiviral vectors (Zufferey et al., 1999;
Ketteler et al., 2002; Brun et al., 2003). In nearly all cases,
the WPRE element was inserted downstream of the actual
transgene as a single copy element.
In this study, we analyzed whether the WPRE mediated
improvement in transgene expression and vector production
is dependent on the site of insertion and/or the number of
inserted elements in a retroviral vector carrying two trans-
genes. A set of ProCon vectors carrying 2 different
heterologous promoters in the U3 region of the 3VLTR
was constructed and used. A 600 bp fragment of the
complete WPRE sequence, retaining 85% of its activity, was
inserted into the retroviral vectors VEA, PCEmCMV, and
PCEhCMV (Fig. 1; Donello et al., 1998). The impact of (i)
the site of insertion – directly downstream of the EGFP
transgene (Fig. 1, vectors VEWA, PCEWmCMV, and
PCEWhCMV), in the 3V untranslated region (3VUTR, Fig.
1, vectors PCEmCMVW and PCEhCMVW), and in both
positions within the same vector (Fig. 1, vectors
PCEWmCMVW and PCEWhCMVW) as well as (ii) the
number of copies of the WPRE sequence introduced into the
vector (Fig. 1, monomer – all abovementioned vectors,
dimer inserted 3V of the EGFP gene as in vectors VE2WA,
PCE2WmCMV, and PCE2WhCMV, and a tetramer 3V of the
EGFP gene – vector VE4W) were analyzed both in
transiently transfected 2GP19Talf packaging cells by
Fig. 1. Retroviral vector constructs. VEA—MLV-based vector (LTR consisting of Unique 3V (U3), Repeated (R) and Unique 5V (U5) regions) containing the
enhanced green fluorescent protein gene (EGFP) as well as an internal SV40 promoter (SV40) controlling expression of the neomycin resistance gene (neo);
VEWA—VEA with the woodchuck hepatitis virus posttranscriptional regulatory element (WPRE) in sense orientation 3V of the EGFP gene; VE2WA and
VE4WA—VEA with a dimer or tetramer of the WPRE in sense orientation 3V of the EGFP gene; PCEmCMV, PCEhCMV—MLV-based ProCon vectors
containing the EGFP gene as well as an internal SV40neo cassette and a hybrid 3VLTR with the murine (mCMV) or human (hCMV) CMV promoter cloned in
the 3VLTR U3 region; PCEWmCMV, PCEWhCMV—PCEmCMV and PCEhCMV with the WPRE in sense orientation 3V of the EGFP gene; PCE2WmCMV,
PCE2WhCMV—PCEmCMVand PCEhCMV with a dimer of the WPRE in sense orientation 3V of the EGFP gene; PCEmCMVW, PCEhCMVW—PCEmCMV
and PCEhCMV with the WPRE in sense orientation cloned into the 3V untranslated region (UTR) of the vector; PCEWmCMVW, PCEWhCMVW—PCEmCMV
and PCEhCMV with two copies of the WPRE, 3V of the EGFP gene as well as in the 3VUTR of the same vector, both in sense orientation.
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well as in infected NIH3T3 cells by determining transgene
expression (Fig. 1).
Generally, in the transfected virus producer cells,
insertion of the WPRE into the basic ProCon vectors
PCEmCMV and PCEhCMV resulted in an increase in
transgene expression independent of the position of the
WPRE within the vector and the WPRE copy number in all
constructs. Introduction of a single WPRE (Fig. 1, vectors
VEWA, PCEWmCMV, PCEWhCMV, PCEmCMVW,
PCEhCMVW) led to a 2- to 3-fold increase in transgene
expression, whereby the insertion of the WPRE 3V of the
EGFP gene (PCEWmCMV, PCEWhCMV) gave slightly
better results compared to a WPRE location in the 3VUTR
(PCEmCMVW, PCEhCMVW) (data not shown). Insertion
of the WPRE monomer both 3V of the EGFP gene and in the
3VUTR of the same vector (Fig. 1, PCEWmCMVW and
PCEWhCMVW) led to a more than 5-fold increase in
transgene expression as compared to PCEmCMV and
PCEhCMV. Insertion of two and four copies of the WPRE(Fig. 1, vectors VE2WA, PCE2WmCMV, PCE2WhCMV,
and vector VE4W), respectively, did not result in further
increases in transgene expression. Similar effects with
respect to the location and number of WPREs on transgene
expression were also observed in infected NIH3T3 cells
(data not shown). Based on these data, it seems that (i) the
WPRE enhances transgene expression both in transfected
packaging cells as well as in infected cells; (ii) insertion of
the WPRE in the proximity of the transgene (3V of the gene
of interest) is superior to the insertion into the 3V
untranslated region of the retrovirus vector; (iii) the
presence of more than one copy of the WPRE does not
further enhance the transgene expression neither in trans-
fected nor in infected cells except if monomers of the
WPRE are inserted both 3V of the transgene and into the
3VUTR of the same vector.
Consistent with the data obtained in transient transfection
experiments, the WPRE improves transgene expression in
stable virus producing cells (Table 1, compare line 1 vs. 2, 3
vs. 4/5, and 6 vs. 7/8). Surprisingly, in contrast to the data
Table 1
Evaluation of the WPRE effect on transgene expression, virus production, and virus titer
Virus vectora MFI in transfected cellsb Real-time titerc EGFP titerd MFI in infected cellse
1 VEA 1.0 T 0.0 1.0 T 0.0 1.0 T 0.0f 1.0 T 0.0
2 VEWA 5.5 T 1.4 1.4 T 0.6 2.0 T 1.5 2.7 T 0.4
3 PCEmCMV 1.0 T 0.0 1.0 T 0.0 1.0 T 0.0 1.0 T 0.0
4 PCEWmCMV 4.4 T 0.5 1.8 T 0.2 2.2 T 0.7 4.1 T 0.5
5 PCEWmCMVW 5.0 T 0.2 3.5 T 0.4 2.1 T 0.2 10.1 T 0.6
6 PCEhCMV 1.0 T 0.0 1.0 T 0.0 1.0 T 0.0 1.0 T 0.0
7 PCEWhCMV 4.5 T 0.2 2.1 T 0.6 7.4 T 1.6 1.7 T 0.5
8 PCEWhCMVW 5.1 T 0.1 2.8 T 0.6 8.7 T 0.4 2.3 T 0.1
All values are calculated relative to the data – set as 1 – obtained with the corresponding vector lacking the WPRE.
a 2GP19Talf cells were stably transfected with a variety of vector plasmids.
b The expression of EGFP in the packaging cells was monitored by mean fluorescence intensity (MFI) measurement.
c The number of virion containing RNA in the supernatant of the packaging cells was evaluated by real-time RT-PCR (real-time titer).
d The efficiency of infection of NIH3T3 cells was measured by determination of the percentage of green cells via FACS analysis 48 h postinfection (EGFP titer).
e Expression of EGFP in the infected cells was monitored by MFI measurement.
f Average absolute infectious titer has been 1  106 gfu/ml.
Fig. 2. Effect of the WPRE on transgene expression in infected cells.
Different mouse and human cell lines were infected with viruses harboring
the WPRE (VEWA—black column, PCEWmCMV—grey column,
PCEWhCMV—white column) as well as with their parental counterparts
lacking the WPRE (VEA, PCEmCMV, PCEhCMV). Forty-eight hours
postinfection the expression of the EGFP was monitored by measuring the
MFI. Relative transgene expression with respect to the transgene expression
(relative MFI) in cells infected with the parental vectors VEA, PCEmCMV,
and PCEhCMV (always set as an arbitrary unit equal to 1), respectively, is
shown for each vector and cell line combination.
J. Hlavaty et al. / Virology 341 (2005) 1–114obtained after transient vector transfection, no significant
differences were observed between vectors PCEWmCMV
vs. PCEWmCMVW and PCEWhCMV vs. PCEWhCMVW
(Table 1, lines 4 vs. 5 and 7 vs. 8). Increased transgene
expression in virus producing cells was accompanied by an
increase in the number of packaged vector genomes in cell
culture supernatants from the vector producing cells, in the
amount of infective virus particles as well as in transgene
expression in infected NIH3T3 cells (Table 1, compare line
1 vs. 2, 3 vs. 4/5 and 6 vs. 7/8). However, these observations
are in contradiction to those from Zufferey et al. (1999) and
Mautino and Morgan (2002), in which the presence of the
WPRE did not affect vector titer and infectivity, respec-
tively. This might be due to the fact that in our vector system
the produced vector RNA is the limiting factor for virus
production, and thus virus production will be enhanced by
providing greater amounts of vector RNA facilitated by the
activity of the WPRE.
In line with the results obtained in transient transfection
experiments, the maximal positive effect on transgene
expression and virus production as compared to corre-
sponding vectors lacking WPRE was achieved using
vectors containing monomers of the WPRE inserted 3V of
the gene of interest and in the 3VUTR of the same vector
(PCEWmCMVW and PCEWhCMVW, respectively). Even
though these vectors were superior to all other vectors
tested, the potential risk of recombination between the two
identical WPRE sequences inserted close to each other, has
to be taken into consideration. Thus, viruses harboring only
a WPRE monomer downstream of the transgene were used
to analyze the WPRE effect in different recipient cells.
Infection of mouse (PAN02) and human (293 HEK, PANC-
1, MiaPaca-2, and Paca44) cell lines with vectors VEWA,
PCEWmCMV, and PCEWhCMV revealed increased trans-
gene expression up to 5-fold for VEWA, 4-fold for
PCEWmCMV, and 3-fold for PCEWhCMV as compared
to the respective vectors without the WPRE (VEA,
PCEmCMV, PCEhCMV; Fig. 2). Consistent with published
data, the actual level of increase of expression wasdependent on the type of recipient cells used and the
promoter selected to control transgene expression (Rame-
zani et al., 2000; Brun et al., 2003).
Neither the mouse RTE nor the viral CTE is able to enhance
virus production and transgene expression in context of an
MLV retroviral vector
In this study, the effects of the CTE and RTE RNA
transport elements on transgene expression and vector
production in context of the retroviral ProCon vector
PCEmCMV were analyzed alone, in combination, or
together with the WPRE. First, the impact of the site of
insertion was evaluated in transient transfection/infection
experiments. The CTE, RTE, or both elements together
were selectively inserted into the 3VUTR of the retroviral
vectors (Fig. 3, vectors PCEmCMVR, PCEmCMVC, and
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is located in SRV1 and MPMV, (ii) the RTE is located in
the 3V region of the IAP retroelements, and (iii) it was
reported that the CTE needs to be located at a certain
distance to the poly(A) signal of the RNA to be functional
(Bray et al., 1994; Zolothukin et al., 1994; Rizvi et al.,
1997; Nappi et al., 2001). An insertion site immediately
downstream of the EGFP transgene (Fig. 3, vectors
PCERmCMV, PCERCmCMV) was chosen as a second
site of insertion since in this case only proviral RNA
produced from the promoter in the retrovirus 5VLTR is
expected to be affected, while shorter RNA molecules
transcribed from the internal SV40 promoter remain
unaffected. This might be of importance in case the poolFig. 3. Retroviral vector constructs harboring the RTE and/or CTE based on ProC
orientation cloned into the 3VUTR of the vector; PCEmCMVC—PCEmCMV ca
PCEmCMVRC—PCEmCMV with a combination of RTE and CTE in sense orient
the RTE in sense orientation 3V of the EGFP gene; PCERCmCMV—PCEmCMV
EGFP gene; PCEWmCMVR—PCEmCMV with the WPRE in sense orientation 3V
the same vector; PCEWmCMVC—PCEmCMV with the WPRE in sense orientat
3VUTR of the same vector; PCEWmCMVRC—PCEmCMV with the WPRE in sen
cloned into the 3VUTR of the same vector; PCERmCMVW—PCEmCMV with
orientation cloned into the 3VUTR of the same vector; PCERmCMVWC—PCE
combination of WPRE and CTE in sense orientation cloned into the 3VUTR of the s
sense orientation cloned into the 3VUTR of the same vector; and finally PCEmC
cloned into the 3VUTR of the same vector.of proteins assisting in the cellular RNA transport machi-
nery is limited. Transgene expression in 2GP19Talf cells
producing these vectors as well as in infected mouse
NIH3T3 and human HeLa cells did not reveal any
significant increase in mean fluorescence intensity (MFI)
of EGFP (data not shown). Interestingly, the combination of
RTE and CTE actually appears to reduce transgene
expression in infected mouse cells (NIH3T3) but not in
infected human cells (HeLa, data not shown). This is
different to the data obtained by Smulevitch et al. (submitted
for publication) who showed a strong synergistic effect on
RNA export when combining RTE and CTE in a lentiviral
context. Surprisingly, constructs harboring RTE and/or CTE
cloned in antisense orientation displayed slightly betteron vector PCEmCMV. PCEmCMVR—PCEmCMV with the RTE in sense
rrying the CTE in sense orientation cloned into the 3VUTR of the vector;
ation cloned into the 3VUTR of the vector; PCERmCMV—PCEmCMV with
with a combination of RTE and CTE in sense orientation cloned 3V of the
of the EGFP gene and the RTE in sense orientation cloned into the 3VUTR of
ion 3V of the EGFP gene and the CTE in sense orientation cloned into the
se orientation 3V of the EGFP gene and RTE and CTE in sense orientation
the RTE in sense orientation 3V of the EGFP gene and WPRE in sense
mCMV with the RTE in sense orientation 3V of the EGFP gene and a
ame vector; PCEmCMVCW—PCEmCMV with the CTE and WPRE both in
MVWC—PCEmCMV with the WPRE and CTE both in sense orientation
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and/or CTE cloned in sense orientation (data not shown).
This is a clear contradiction to the RTE function in the
context of a lentivirus, where RTE activity was only
shown when inserted in sense orientation, whereas
insertion in the opposite transcriptional orientation resulted
in a failure to produce viruses (Nappi et al., 2001). These
data reveal that the restriction in expression of MLV is
distinct from that of lentiviruses and that different
restrictions may apply to different mRNAs. Thus, individ-
ual elements within different RNAs studied may function
differently, or may be inactive.
To see whether the WPRE mediated effect can be further
potentiated by insertion of an alternative RNA transport
element, vectors harboring the RTE, the CTE, or both in the
3VUTR in addition to the 3V of the EGFP gene located WPRE
(Fig. 3, vectors PCEWmCMVR, PCEWmCMVC, and
PCEWmCMVRC), containing the RTE 3V of the EGFP gene
and the WPRE in the 3VUTR (Fig. 3, PCERmCMVW), or
carrying a combination of the WPRE and the CTE in the
3VUTR with (Fig. 3, PCERmCMVWC) or without (Fig. 3,
PCEmCMVWC, PCEmCMVCW) the RTE 3V of the EGFP
were constructed and analyzed. No major differences in
transgene expression between vectors harboring WPRE
alone and those carrying the WPRE and the RTE and/or
CTE in any combination and position were observed in
transiently and stable transfected virus producer cells (Table
2, MFI in producer cells) as well as in infected NIH3T3 and
HeLa cells (Table 2, MFI in infected cells). Surprisingly,
however, differences in MFI between infected mouse
NIH3T3 and human HeLa cells were detected. No positive
effect of the two transport elements on virus production was
observed (Table 2, real-time titer, EGFP titer). A possibleTable 2
Effects of the RTE and/or CTE in a retroviral vector on transgene expression, vi
Virus vectora MFI in producer cellsb Real-time tite
1 PCEmCMV 1.0 T 0.0 1.0 T 0.0
2 PCEmCMVW 2.7 T 0.1 3.0 T 0.8
3 PCEmCMVR 1.1 T 0.1 0.8 T 0.3
4 PCEmCMVRasn 1.5 T 0.1 2.4 T 0.0
5 PCEmCMVRC 1.1 T 0.1 1.1 T 0.4
6 PCEmCMVRCasn 0.8 T 0.1 2.0 T 1.4
7 PCEmCMVC 1.0 T 0.0 4.2 T 2.2
8 PCEmCMVCasn 1.4 T 0.1 1.2 T 0.7
9 PCEWmCMV 4.4 T 0.5 1.8 T 0.2
10 PCERmCMV 0.8 T 0.0 2.6 T 1.0
11 PCERmCMVasn 1.0 T 0.0 1.5 T 0.7
12 PCERCmCMV 1.5 T 0.5 1.5 T 0.5
13 PCERCmCMVasn 2.2 T 0.1 3.1 T 0.9
All values shown are relative to those obtained with the parental vector PCEmCM
a 2GP19Talf cells were stably transfected with a variety of vector plasmids.
b The expression of EGFP in the packaging cells was monitored by MFI measu
c The number of virion containing RNA in the supernatant of the packaging ce
d The efficiency of infection of NIH3T3 cells was measured by determining the
e Expression of EGFP in the infected cells was monitored by MFI measuremenexplanation for this, as well as for the lack of improvement in
transgene expression, is that the major splice acceptor is not
present in the ProCon vector as in most retroviral vectors. The
CTE function is suspected to be an accelerator of export of
unspliced RNA, at least in messages where splicing occurs,
and is thereby shifting the balance in favor of the full length
message instead of spliced transcripts (Schambach et al.,
2000). Thus, it is unlikely that an increase of unspliced
exported ProCon vector messages can be seen in our system,
where splicing will not occur. A second explanation might be
that the transport elements, which are known to be highly
structured themselves, influence the overall secondary
structure of the vector RNA thereby decreasing RNA stability
or translation efficiency. This would, however, implicate that
the WPRE acts not at the level of nucleocytoplasmic RNA
export, but rather constitutes a translational enhancer, as has
been previously described (Schambach et al., 2000).
To rule out the possibility that the obtained data are cell-
specific and therefore not representative, we analyzed the
effect of the RTE/CTE on transgene expression in various
cell lines of mouse and human origin. Mouse PAN02 and
NMuMG cells as well as human PANC-1, Paca44,
MiaPaca-2, and BxPc-3 cells were infected with super-
natants from cells stably producing the various retroviral
vectors. In line with the previous observation, the effect of
the RTE/CTE on transgene expression in infected mouse
cells was rather negative for all constructs harboring the
transport elements in sense orientation and negligible for
constructs carrying them in antisense orientation as com-
pared to the corresponding vector without the WPRE (data
not shown). In the infected human cells, the RTE/CTE effect
on transgene expression was negligible in either orientation
(data not shown).rus production, and virus titer
rc EGFP titerd NIH3T3 MFI in infected cellse
NIH3T3 HeLa
1.0 T 0.0 1.0 T 0.0 1.0 T 0.0
2.7 T 0.1 2.2 T 0.1 2.0 T 0.4
1.3 T 0.3 0.6 T 0.0 1.1 T 0.5
0.9 T 0.2 1.3 T 0.1 1.1 T 0.5
1.1 T 0.3 0.4 T 0.1 1.1 T 0.5
0.1 T 0.1 1.0 T 0.1 1.1 T 0.5
0.3 T 0.3 0.4 T 0.1 0.9 T 0.4
0.7 T 0.5 1.2 T 0.1 1.1 T 0.5
2.2 T 0.7 4.1 T 0.5 3.9 T 2.1
2.2 T 0.7 0.4 T 0.0 0.5 T 0.2
1.5 T 0.4 1.7 T 0.2 1.1 T 0.5
0.4 T 0.3 0.1 T 0.0 0.7 T 0.4
1.2 T 0.3 1.4 T 0.1 1.5 T 0.6
V.
rement.
lls was evaluated by real-time RT-PCR (real-time titer).
percentage of green cells by FACS analysis 48 h postinfection (EGFP titer).
t.
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of both elements used here can exert their described
function as RNA transport elements, lentiviral constructs
carrying a truncated HIV genome with a deleted rev/RRE
system but with intact RNA export inhibiting gag gene
sequences (pNLgag), and with the respective RTE/CTE
elements (pNLgagM26, pNLgagCTE, pNLgagM26CTE)
were tested for gag-mRNA export using an HIV-1 Gag-
specific capture ELISA. Compared to the lentiviral
construct pNLgag containing none of the RTE and/or
CTE elements, a 12-fold higher Gag level was detected in
cells transfected with the RTE/CTE containing vector
pNLgagM26CTE (data not shown). A 5-fold increase was
observed in cells transfected with the CTE only containing
vector pNLgagCTE and a modest 1.5-fold increase in cells
transfected with the RTE containing vector pNLgagM26
(data not shown). Even if the RTE alone does not seem to
significantly increase the HIV-gag expression, in combina-
tion with the CTE, it shows a strong synergistic effect in a
lentiviral construct which is in agreement with a previous
observation of studying this combination of elements in
poorly expressed lentiviral mRNAs (Smulevitch et al.,
submitted for publication), but as already shown above, not
in a retroviral construct.
Based on these data, it seems that (i) neither the RTE
nor the CTE enhances transgene expression in retroviral
vector transfected packaging cells as well as in infected
cells, (ii) thus, no position dependence of the RTE/CTE
(insertion 3V of the transgene vs. insertion into the 3VUTR
of the vector) was detected, (iii) multimerization of the
RTE or CTE does not enhance transgene expression,
neither in transfected nor in infected cells, and (iv) the
only positive effect on transgene expression is achieved
when the RTE and/or CTE is/are present in combination
with the WPRE within the same vector. However, this
effect is similar to that achieved with virus harboring the
WPRE only and thus seems to be solely dependent on the
activity of the WPRE.Fig. 4. Retroviral vector constructs harboring the human Hsp70 5VUTR. VUEA—V
VUEA—VUEA containing the WPRE in sense orientation 3V of the EGFP gene
upstream of the EGFP gene; PCUEWmCMV—PCUEmCMV carrying the WPREEffect of the Hsp70 5VUTR on transgene expression and
virus production
To study the effect of the Hsp70 5VUTR on translation in
a retroviral context, we inserted the 218 bp long Hsp70
5VUTR fragment immediately upstream of the ATG codon
of the EGFP gene into vectors VEA, VEWA, PCEmCMV,
and PCEWmCMV and transfected the resulting plasmids
pVUEA, pVUEWA, pPCUEmCMV, and pPCUEWmCMV
(Fig. 4) stably into 2GP19Talf packaging cells. No increase
in transgene expression and virus production from these
cells was observed when compared to stable virus
producers carrying the corresponding vectors VEA,
VEWA, PCEmCMV, and PCEWmCMV (Table 3, MFI in
producer cells). NIH3T3 cells infected with the respective
viruses as well revealed no enhanced EGFP synthesis (Table
3, MFI in infected cells). Since the Hsp70 5VUTR sequence
which is known to form strong secondary structures is
inserted in close proximity to the extended packaging signal
which also forms a strong secondary structure, one might
expect interaction or sterical inhibition of these elements
leading to a decrease in the function of one or both
sequences, i.e. a reduced ability of the proviral RNA to be
packaged. However, real-time RT-PCR analyses of virus
supernatant revealed no reduction in the amount of infectious
virus particles produced from cells carrying vectors with the
Hsp70 5VUTR compared to cells producing Hsp70 5VUTR
deficient vectors (Table 3, compare real-time titer and EGFP
titer of vectors with and without the Hsp70 5VUTR).
To exclude the possibility that the secondary structure of
the packaging signal is somehow negatively influencing the
action of the Hsp70 5VUTR as a translational enhancer,
eukaryotic expression constructs harboring EGFP gene with
(pCOX-2UEGFP) and without (pCOX-2EGFP) the Hsp70
5VUTR under the control of cyclooxygenase-2 promoter
were transfected into human 293 HEK and PANC-1 cells.
Interestingly, consistent with the data obtained in NIH3T3
cells infected with the retroviral Hsp70 5VUTR-constructs,EAwith the Hsp70 5VUTR cloned immediately upstream of the EGFP gene;
; PCUEmCMV—PCEmCMV with the Hsp70 5VUTR cloned immediately
in sense orientation 3V of the EGFP gene.
Table 3
Effects of the Hsp70 5VUTR in context of a retroviral vector on transgene expression, virus production, and virus titer
Virus vectora MFI in producer cellsb Real-time titerc EGFP titerd MFI in infected cellse
1 VEA 1.0 T 0.0 1.0 T 0.0 1.0 T 0.0 1.0 T 0.0
2 VUEA 2.4 T 0.1 0.9 T 0.3 0.9 T 0.1 1.4 T 0.1
3 VEWA 1.0 T 0.0 1.0 T 0.0 1.0 T 0.0 1.0 T 0.0
4 VUEWA 1.4 T 0.1 1.2 T 0.5 1.0 T 0.1 1.6 T 0.1
5 PCEmCMV 1.0 T 0.0 1.0 T 0.0 1.0 T 0.0 1.0 T 0.0
6 PCUEmCMV 1.3 T 0.1 1.3 T 0.2 1.5 T 0.3 1.4 T 0.1
7 PCEWmCMV 1.0 T 0.0 1.0 T 0.0 1.0 T 0.0 1.0 T 0.0
8 PCUEWmCMV 1.0 T 0.1 0.9 T 0.1 0.9 T 0.1 1.4 T 0.1
Values shown are calculated relative to the corresponding vectors lacking the Hsp70 5VUTR.
a 2GP19Talf cells were stably transfected with a variety of vector plasmids.
b The expression of EGFP in the packaging cells was monitored by MFI measurement.
c The number of virion containing RNA in the supernatant of the packaging cells was evaluated by real-time RT-PCR (real-time titer).
d The efficiency of infection of NIH3T3 cells was measured by determining the percentage of green cells by FACS analysis 48 h postinfection (EGFP titer).
e Expression of EGFP in the infected cells was monitored by MFI measurement.
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observed an up to 10-fold increase in gene expression, an
only slight, non-significant increase in EGFP synthesis was
observed (data not shown).
In this light, it should be mentioned that much of the
published data regarding the role of 5V untranslated regions
as translational enhancers are controversial. Stein et al.
(1998), for example, obtained a 40-fold increase in secreted
alkaline phoshatase (SEAP) protein expression from a
monocistronic expression vector harboring a 163bp long
SP163 element, derived from the 5VUTR of the vascular
endothelial growth factor (VEGF). The activity of this IRES
like element was shown to be independent of the cell type
used. In contrast, Johansen et al. (2003) recently described a
reduction in SEAP protein levels in rat cells transfected with
constructs containing the SP163 translational enhancer.
Previously, the presence of an IRES in the leader
sequence in the different strains of the murine leukemia
virus as well as in the mouse VL30 retrotransposon was
described (Vagner et al., 1995; Berlioz and Darlix, 1995;
Lopez-Lastra et al., 1999). This sequence co-locates with
the elongated packaging signal which is also present in the
ProCon vectors. Very recently, an internal ribosome entry
site (IRES) with a similar activity to the classical picorna-
virus IRES elements has been discovered within the Hsp70
5VUTR sequence (Rubtsova et al., 2003). In spite of these
data, it seems unlikely that an additional benefit on
transgene expression can be obtained from linking two
IRES sequences due to sterical hindrance, a theory which
would be supported by our data.
In summary, our studies demonstrate that among the four
posttranscriptionally acting elements (WPRE, RTE, CTE,
and Hsp70 5VUTR) analyzed here, only the insertion of the
WPRE led to a reasonable increase in vector performance in
terms of expression of the vector-inserted transgene. Thus,
these data may be helpful for construction of optimized and
improved retrovirus vectors for gene therapy harboring the
WPRE but also for saving efforts on further evaluation of
the less favorable elements.Materials and methods
Plasmid construction
The DNA sequence containing a fragment of the
WPRE (GenBank accession no. J02442, pos. 1086–
1694) was amplified by PCR from plasmid pSPWAS using
specific primers with NotI and ClaI restriction sites,
respectively, and subsequently cloned into plasmid
pCR2.1 (Invitrogen). The resulting plasmids were named
(in accordance to the restriction site in the primer) pWPRE
CC, pWPRE NC, pWPRE CN, and pWPRE NN. To
construct retrovirus vectors VEWA, PCEWmCMV, and
PCEWhCMV, the WPRE was released from plasmid
pWPRE NN by digestion with NotI and inserted into the
appropriate vector plasmids pVEA, pPCEmCMV, and
pPCEhCMV, previously linearized with NotI (Hlavaty et
al., 2004a, 2004b). To generate retrovirus vectors with a
dimer of the WPRE 3V of the EGFP gene, plasmids pWPRE
NC and pWPRE CN were digested with NotI and ClaI.
Subsequently, the WPRE-containing fragments were ligated
to NotI-linearized plasmids pVEWA, pPCEWmCMV, and
pPCEWhCMV in a three fragment ligation. The resulting
constructs were named pVE2WA, pPCE2WmCMV, and
pPCE2WhCMV. Additionally, the vector VE4WA, harbor-
ing four copies of the WPRE (two dimers), was cloned
using the same strategy as described above. To obtain
vectors pPCEmCMVW, pPCEhCMVW, pPCEWmCMVW,
and pPCEWhCMVW, which carry a copy of the WPRE in
the 3V untranslated region (UTR) of the retrovirus vectors,
the 600 bp ClaI fragment of pWPRE CC was inserted into
plasmids pPCEmCMV, pPCEhCMV, pPCEWmCMV, and
pPCEWhCMV linearized with ClaI.
An up-regulatory mutant of the mouse RNA transport
element RTEm26 (further indicated as RTE), the simian
retrovirus type D constitutive transport element (CTE), and
a cassette containing both RTE and CTE were PCR
amplified from plasmid pNLgagM26CTE (Smulevitch et
al., 2005) using specific primers with restriction site
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pCR2.1. The resulting plasmids were named in accordance
with the insert and the restriction sites in the primers as
pRTE NN, pRTE NC, pRTE CC, pRTE CN pCTE CC,
pCTE CN, pCTE NC, pRTECTE NN, and pRTECTE CC.
For all cloning strategies used in this study, T4 DNA
polymerase was used to convert sticky ends to blunt ends.
To obtain plasmid pPCEmCMVR, the blunted EcoRI
fragment containing the full length RTE from pRTE NN
was ligated to the ClaI-linearized and blunted vector
pPCEmCMV. Similarly, the RTE-CTE-containing EcoRI
fragment of plasmid pRTECTE NN was treated with T4
DNA polymerase and ligated to the ClaI-linearized, T4
DNA polymerase treated vector pPCEmCMV giving rise to
vector PCEmCMVRC. The CTE released from plasmid
pCTE CC by ClaI digestion was inserted into the ClaI-
linearized vector pPCEmCMV to generate plasmid
pPCEmCMVC. AgeI–Csp45I DNA fragments containing
the EGFP gene and the SV40neo cassette of plasmids
pPCEmCMVR, pPCEmCMVC, and pPCEmCMVRC were
replaced by the AgeI–Csp45I fragment of PCEWmCMV
containing the EGFP, WPRE, and SV40neo sequences. The
resulting constructs were named PCEWmCMVR,
PCEWmCMVC, and PCEWmCMVRC. To clone vectors
pPCERmCMV and pPCERmCMVW, the NotI-released
RTE fragment of plasmid pRTE NN was ligated to the
NotI-linearized vectors pPCEmCMV and pPCEmCMVW.
Similarly, the NotI-released RTE-CTE fragment from
pRTECTE NN ligated to Not I-linearized plasmid
pPCEmCMV yielded pPCERCmCMV plasmid. Vector
pPCEmCMVCW was cloned by triple ligation of the
CTE fragment released from plasmid pCTE CN by ClaI–
NotI double digestion, the WPRE fragment released from
plasmid pWPRE NC by NotI and ClaI digestion, and the
Cla I-linearized plasmid pPCEmCMV. Similarly,
pPCEmCMVWC was created by ligation of the WPRE
fragment from plasmid pWPRE CN (released with ClaI
and NotI), the CTE fragment from plasmid pCTE CN
(released with NotI and ClaI), and the ClaI-linearized
plasmid pPCEmCMV. The AgeI–Csp45I fragment of
pPCEmCMVWC containing the viral LTRs was ligated
with the EGFP-containing AgeI–Csp45I fragment of
pPCERmCMV to yield pPCERmCMVWC. Plasmid
pNLgagM26 was obtained from plasmid pNLgagM26CTE
by XbaI–SalI excision of the CTE followed by self-ligation
of the T4 DNA polymerase treated backbone, whereas
plasmid pNLgagCTE was constructed by removing the RTE
element after digestion with ClaI. To create pNLgag, a
SacII–SalI digestion of plasmid pNLgagM26CTE was used
to remove the RTE and CTE elements, the backbone was
treated with T4 DNA polymerase and self-ligated.
Genomic DNA from 293 human embryonal kidney cells
(293 HEK) was isolated using a DNeasy Tissue Kit
(Qiagen) according to the manufacturer’s recommendation.
The Hsp70 5VUTR (GenBank accession no. M11717, pos.
276–488) was PCR amplified using specific primerscarrying recognition sites for EcoRI (forward primer) and
NcoI (reverse primer) and the genomic DNA from 293 HEK
cells as template. Amplified fragments were subsequently
cloned into plasmid pCR2.1 giving rise to plasmid
pHsp70UTR. The identity of the cloned insert was
confirmed by sequencing. A 218 bp EcoRI–NcoI fragment
of pHsp70UTR was inserted into the 4510 bp EcoRI–NcoI
fragment of pCMLVU3 creating plasmid pCMLVU3H-
sp70UTR (Hlavaty et al., 2004b). To clone pVUEA and
pVUEWA, the 1051 bp BsrGI fragment of pCMLVU3H-
sp70UTR was ligated to the 5835 bp BsrGI fragment of
pVEA and the 6444 bp BsrGI fragment of VEWA,
respectively. To produce pPCUEmCMV, the 1969 bp
AscI–NotI fragment of pCMLVU3Hsp70UTR was ligated
with the 7286 bp AscI–NotI fragment of pPCEmCMV. A
609 bp NotI fragment from pWPRE NN was inserted into
pPCUEmCMV linearized with NotI to create plasmid
pPCUEWmCMV.
A short 400 bp fragment of the cyclooxygenase-2
promoter (GenBank accession no. AF276953, pos. 863–
1260) was amplified from plasmid pCOXsd2EGFP (kindly
provided by Dr. Holzmu¨ller) using specific primers and
subcloned into plasmid pCR2.1 to create plasmids
pCR2.1COX-2s sen and pCR2.1COX-2s asn. The pro-
moter-containing EcoRV–HindIII fragment of pCR2.
1COX-2s asn was ligated to the NruI–HindIII backbone
fragment of pCMVEGFP (Walter et al., 2000). The resulting
construct pCOX-2EGFP was digested with SpeI and NcoI
and ligated to the NcoI –SpeI fragment of plasmid
pHsp70UTR harboring the Hsp70 5VUTR sequence. The
final plasmid was named pCOX-2UEGFP.
Cell culture and FACS analysis
Human 2GP19Talf amphotropic retroviral packaging
cells (Pambalk et al., 2002), 293 HEK cells (ATCC CRL-
1573), HeLa cells (ATCC CCL-2), HeLa cells stably
expressing the HIV-1 tat gene (HLtat, Felber et al.,
1990), PANC-1 (ATCC CRL-1469), Paca-44 (Lo¨hr et al.,
1994), MiaPaca-2 (ATCC CRL-1420), PAN02 (Corbett et
al., 1984), and NMuMG (ATCC CRL-1636) were grown
in Dulbecco’s modified Eagle’s medium (DMEM/Gluta-
max; Life Technologies) supplemented with 10% foetal
calf serum (FCS, Life Technologies). NIH3T3 cells
(ATCC CRL-1658) were maintained in DMEM/Gluta-
max/5% FCS (Owens, 1974) and BxPc-3 cells (ATCC
CRL-1687) in RPMI medium supplemented with 10%
FCS. Transfection, infection, and analysis of cells via
FACS were performed as described elsewhere (Hlavaty et
al., 2004b).
RNA extraction and real-time RT-PCR
Viral RNA extraction from cell culture supernatants and
real-time RT-PCR was performed as described previously
(Hlavaty et al., 2004a).
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The HIV-1 p24 Antigen Capture Assay Kit (Biological
Products Laboratory, Frederick Cancer Research and Devel-
opment Center, Frederick, MD) was used to estimate the
amount of the HIV-1 Gag protein in the samples. HLtat cells
were transiently co-transfected with 0.5 Ag of plasmid
pCMV-dsRed-EXPRESS (Clontech) and 4.5 Ag of gag-gene
containing plasmids pNLgagM26CTE, pNLgagM26,
pNLgagCTE, and pNLgag using the ExGen transfection
reagent (MBI Fermentas) according to the manufacturer’s
recommendation. Forty-eight hours later, cells were har-
vested and lysed in 1% Triton X-100 (Sigma) by repeated
freezing and thawing. Protein concentration was estimated
using a Protein Dc Assay Kit (Bio-Rad). 10 Ag of total protein
extract per well was used for HIV-1 p24 ELISA detection
according to the instructions provided by the manufacturer.Acknowledgments
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